Radiometer is a leading provider of technologically advanced acute care solutions that simplify and automate all phases of acute care testing. Radiometer offers solutions for blood gas analysis, transcutaneous monitoring and immunoassay testing for cardiac, coagulation, infection and pregnancy markers.
By providing fast and accurate acute diagnostic results, healthcare professionals can make immediate and well-informed decisions that enable them to improve patient care and optimise patient flow in all acute care settings – intensive care units (ICUs), emergency departments (EDs) and operating rooms (ORs).
Founded in 1935 and headquartered in Copenhagen, Denmark, Radiometer was a pioneer in blood gas testing, introducing the world’s first commercially available blood gas analyser in 1954.
Radiometer’s products and services are available in more than 100 countries around the world through wholly-owned subsidiaries and approved distributors.
Radiometer is a part of the US-based Danaher Corporation with approximately 48,000 employees distributed across 50 different companies worldwide (NYSE:DHR).